NL-OMON21880
Not Yet Recruiting
N/A
Towards the development of a personalised E-Health intervention for use in community pharmacies to analyse and improve medication non-adherence in people with type 2 diabetes mellitus, who are non-adherent to oral blood glucose- and/or blood pressure lowering drugs.
Amsterdam UMC, location VUmc0 sites300 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Type 2 diabetes mellitus, medication non-adherence
- Sponsor
- Amsterdam UMC, location VUmc
- Enrollment
- 300
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
.A.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The main inclusion criteria are:
- •1\)People with type 2 diabetes mellitus treated with oral blood glucose lowering drugs;
- •2\)Non\-adherent to oral blood glucose and/or blood pressure lowering drugs;
- •3\)Aged 35\-75 years;
- •4\)Mobile phone user.
Exclusion Criteria
- •The main exclusion criteria are:
- •1\)Use of insulin;
- •2\)People that use medication\-intake supporting services provided by the pharmacy;
- •3\)People that suffer from major psychiatric disorders;
- •4\)People that are ‘starters’, meaning that they started using the medicine somewhere in the period in which the dispensing score was calculated;
- •5\)People that are ‘stoppers’, meaning that they did not have a medicine dispatch in the last four months of the period in which the dispensing score was calculated.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Towards the development of a personalised E-Health intervention for use in community pharmacies to analyse and improve medication non-adherence in people with type 2 diabetes mellitus, who are non-adherent to oral blood glucose and/or blood pressure lowering drugs.NL-OMON55758Vrije Universiteit Medisch Centrum150
Completed
N/A
Improving treatment adherence in people with diabetes mellitusType 2 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN36009809niversity of East Anglia23
Completed
Phase 2
Individually tailored E-health interventions for primary care patients with problematic alcohol use and co-occurring depressive symptoms: Phase IIa - proof of concept studyAt-risk alcohol consumption (average daily intake of alcohol > 12g for women / >24gmen or >= one occasion a month with >= 4 alcoholic drinks for women / >= 5 drinks for men).At-risk alcohol consumption is considered as a risk factor for Harmful Alcohol use (ICD-10F10.1), Alcohol Dependence Syndrome (ICD-10 F10.2), and other alcohol attributable disease.subsyndromal depressive symptoms, majordepression (ICD-10 F32) or dysthymia (ICD-10 F34.1)F10.1: Harmful use of alcoholF10.2: Alcohol dependence syndromF10.1F10.2F32F34.1Depressive episodeDysthymiaDRKS00011635niversitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention141
Completed
Phase 1
Individually tailored E-health interventions for primary care patients with problematic alcohol use and co-occurring depressive symptoms (Phase 1)At-risk alcohol consumption (average daily intake of alcohol > 12g for women / >24g men or >= one occasion a month with >= 4 alcoholic drinks for women / >= 5 drinks for men). At-risk alcohol consumption is considered as a risk factor for Harmful Alcohol use (ICD-10 F10.1), Alcohol Dependence Syndrome (ICD-10 F10.2), and other alcohol attributable disease. subsyndromal depressive symptoms, majordepression (ICD-10 F32) or dysthymia (ICD-10 F34.1)F10.1: Harmful use of alcoholF10.2: Alcohol dependence syndromF10.1F10.2F32F34.1Depressive episodeDysthymiaDRKS00007841niversitätsmedizin Greifswald, Institut für Sozialmedizin und Prävention34
Recruiting
N/A
Stratified physiotherapeutic (blended) care in neck and shoulder complaintsNL-OMON27269HU University of Applied Sciences238